Podiums

All times displayed for Europe/Berlin timezone.

Leadership in the Life Sciences
11:00 - 11:45 80B10
World of Pharma Podium
Pincipal Advisor
Pragmedic Limited

Is leadership in the pharma and medtech sectors any different from other business? If so, what makes it different and what are the most important lessons the leaders of this industry have learned? In this session, Professor Brian D Smith will reveal the results of interviewing 23 CEOs and other C-level leaders, including:

•The four exceptional factors that shape leaders in our industry
•The most important challenge facing any life science leader
•What they have learned about building and leading strong leadership teams
•What advice they would give their younger selves.

The session will be relevant to both established and aspiring leaders in pharma and medtech, in any function and in any part of the industry.

Panel discussion: Global Trends in Natural Extracts
11:00 - 12:00 41K01
Natural Extracts Podium
Vice President Content – Health & Nutrition
Informa Markets
Chief Science Officer
American Herbal Products Association
EVP Commercial Development
Avicanna Inc.
CEO
Phytochemks
Global Principal, Consumer Health R&D
IQVIA

• From consumer demand for naturals to meaningful innovation and benefits
• Clinical trials and Real-World Evidence as key elements to demonstrate the important role of naturals in health
• Innovation strategies for established natural products
• Holistic health concepts around naturals in combination with evolving

Brexit and the implications for Pharma – is it a deal or no deal?
11:45 - 12:30 80B10
World of Pharma Podium
Global Head & Executive Vice President of Healthcare Operations & Strategy
GlobalData PLC

It has been about three years since the UK voted to leave the EU. Businesses were told a vote to leave the EU would drive the UK into a severe recession, yet markets are up. Over the past 18 months, GlobalData has conducted a quarterly survey with pharmaceutical industry respondents in the UK, US and EU to better understand how their sentiment towards Brexit changed over time and how they expected Brexit to affect the healthcare sector, both within and outside of the UK. The majority of respondents indicate that “No Brexit” is the best outcome but few believe that it is likely. In this presentation, we will examine:
• Outcomes of Brexit – best and most likely outcomes
• Impact on research and manufacturing
• Changes in corporate strategy
• Likelihood of staff or headquarter relocation
• Evolving sentiment over the past 12-18 months

Curcumin - from Ayurveda to Clinical Trials
12:15 - 13:15 41K01
Natural Extracts Podium
Managing Director
LODAAT
Industry Principal- Life Sciences
Frost & Sullivan
Chief Scientific Advisor
Indena
Associate professor
Faculty of Sciences and Mathematics, University of Niš
Lunch Break
12:30 - 13:00 80B10
World of Pharma Podium
Oncology and its Spectrum of Innovation – powered by IQVIA
13:00 - 14:00 80B10
World of Pharma Podium
Senior Consultant
IQVIA
Director, Global Highly Potent & Oncology Platform
CordenPharma International
CEO & Board Member
Zaphyr Pharma
Consultant, Thought Leadership
IQVIA

Sponsored by:

• Incremental vs breakthrough innovation
• Small molecules and biologics
• Access to innovative medicines

Blending the Natural with the Chemical – Finding the balance between natural extracts and pharma
13:30 - 14:30 41K01
Natural Extracts Podium
Managing Director
LODAAT
Africa and the Middle East - Still a promise or real business?
14:00 - 14:45 80B10
World of Pharma Podium
Managing Partner
Infomineo
Vi-spo by Vidya Herbs, a new botanical extract clinically proven for urinary comfort and quality of life for aging men
14:30 - 15:00 41K01
Natural Extracts Podium
Director of Innovation
Vidya Europe

Sponsored by:

Digital disruption is knocking – is healthcare ready?
14:45 - 15:30 80B10
World of Pharma Podium
Global Head & Executive Vice President of Healthcare Operations & Strategy
GlobalData PLC

The healthcare industry is preparing to ride the digital wave and advances in technology are beginning to have impact across the entire spectrum of the value chain, from the lab to the clinic and beyond. Supply chains are starting to evolve, as new players take on increasingly important roles. Drug and medical device manufacturers will continue to provide much of the equipment and consumables to healthcare providers. However, technology players such as manufacturers of medical sensors, wearable devices, and robots will play an increasingly important role. How key technologies such as AI, blockchain, biosensors, robotics and 3D printing will provide opportunities for healthcare in the near term?

Natural Cannabinoids in the Management of Neurological Disorders and Chronic Pain
15:00 - 15:30 41K01
Natural Extracts Podium
Chief Medical Officer
Avicanna. Inc

Sponsored by:

US Market Highlights and Emerging Opportunities for Cell and Gene Therapy
15:30 - 16:15 80B10
World of Pharma Podium
Director - Business Expansion Services
Greater Philadelphia
Member
Cozen O’Connor

Sponsored by:

The 21st Century Cures Act – signed into law in December 2016 - directs the FDA to accelerate medical product development and bring new innovations and advances to patients who need them- faster, and more efficiently.

Meanwhile, the FDA has approved the first cell and gene therapies in the United States, both of which originated in Philadelphia. The pace of investment in precision medicine is happening at a groundbreaking clip in Greater Philadelphia, and the market trends favor further development in this geographic region of the United States.